LOG IN

News

News

United Rheumatology Newsfeed

news-page-logo

2019 National Meeting Schedule Announced

Held twice a year, United Rheumatology’s National Meetings offer timely and relevant educational sessions delivered by key industry leaders. Topics typically include payer strategies, CMS, clinical pathways, and competitive drug pricing, and are...
Read More

Healio Newsfeed

2_objects@2x_3

Direct-to-consumer genetic testing not ready for prime time in rheumatology

Splashy headlines in the mainstream media that proclaim advances in medicine are often not what they seem. That may be the case with a recent series of FDA approvals surrounding the direct-to-consumer genetic … Read moreDirect-to-consumer genetic testing not ready for prime time in rheumatology

Foot pain prevalence linked to female sex, older age, obesity

Foot pain is associated with female sex, older age and obesity, and its prevalence can range from 13% to 36% depending on which case definition is used, according to data published in Arthritis … Read moreFoot pain prevalence linked to female sex, older age, obesity

CDC: Opioid prescriptions 87% more likely in rural areas

Residents of the most rural locations in the United States were nearly 90% more likely to receive an opioid prescription than residents of large central metropolitan locations during a recent 3-year period, according … Read moreCDC: Opioid prescriptions 87% more likely in rural areas

Government shutdown threatens biosimilar approvals, patent litigation

As the ongoing partial government shutdown continues in the United States, the FDA has approximately 5 weeks until drug user fees completely dry up, jeopardizing the review process for new drugs — including … Read moreGovernment shutdown threatens biosimilar approvals, patent litigation

FDA takes unprecedented step to spur OTC naloxone development

The FDA has, for the first time, proactively developed and tested a product label to encourage development of an over-the-counter version of the opioid overdose antidote naloxone, according to an agency statement.The agency’s … Read moreFDA takes unprecedented step to spur OTC naloxone development

CreakyJoints Newsfeed

2_objects@2x

Eating Only This Many Calories a Day Could Lower Psoriatic Arthritis Disease Activity

A strict diet led to major improvements in swollen joint count, CPR levels, and other measures of disease activity. The post Eating Only This Many Calories a Day Could Lower Psoriatic Arthritis Disease … Read moreEating Only This Many Calories a Day Could Lower Psoriatic Arthritis Disease Activity

What Is Anti-CCP? What It Can Tell You About Your Autoimmune Disease

As you go through the process of getting diagnosed with an autoimmune disease, you’ll be confronted with a slew of tests — most of which you’d probably never heard of before. Rheumatoid arthritis … Read moreWhat Is Anti-CCP? What It Can Tell You About Your Autoimmune Disease

Rheumatoid Arthritis Risk Factors: Here’s What Really Causes Rheumatoid Arthritis

Knowing the factors that contribute to RA risk can help you mitigate them. The post Rheumatoid Arthritis Risk Factors: Here’s What Really Causes Rheumatoid Arthritis appeared first on CreakyJoints.

“The Day I Got Diagnosed with Arthritis”: What It Was Really Like for 7 People, and What They Did Next

Learning that you have a chronic, life-altering disease like arthritis is challenging news to swallow, no matter what kind of arthritis you may have, how old you are, or what your other personal … Read more“The Day I Got Diagnosed with Arthritis”: What It Was Really Like for 7 People, and What They Did Next

Gout Drug Febuxostat Benefits Outweigh Its Risks for Some Patients, Says FDA Committee

If you get frequent gout attacks or have evidence that the disease has caused a visible buildup of uric acid crystals (tophi), then your doctor has likely recommended taking a preventive gout medication … Read moreGout Drug Febuxostat Benefits Outweigh Its Risks for Some Patients, Says FDA Committee

FierceHealthcare Newsfeed

2_objects@2x_1

Payer Roundup—CMS approves Medicaid work requirements in Arizona 

CMS has approved Arizona’s waiver for work requirements, making it the eighth state to test them, plus more insurance news.

CMS unveils new payment model aimed at bringing down Part D catastrophic coverage spending 

CMS has unveiled a new payment model for Medicare Part D with the goal of bringing down high drug spending, especially in the catastrophic coverage phase of the benefit.

MedPAC recommends Congress target rebate traps, biosimilars to bring down drug prices

MedPAC issued draft policy recommendations on Friday aimed at controlling drug costs in Medicare Parts B and D. In addition to discussing new ideas, like lowering Part D coinsurance, the commissioners also touched … Read moreMedPAC recommends Congress target rebate traps, biosimilars to bring down drug prices

CVS, Walmart make nice, reach new multi-year deal to keep retail giant in Caremark’s network 

Just days after Walmart announced it would pull out of CVS Caremark’s network, the two sides have resolved their differences and reached a new contract agreement. 

Industry Voices—How data analytics can help physician practices transition to value-based care models

In order to grapple with spending increases, the U.S. healthcare industry is transforming the way physicians are compensated to provide care to patients. Provider groups that embrace this shift now have an opportunity … Read moreIndustry Voices—How data analytics can help physician practices transition to value-based care models

Rheumatology Advisor Newsfeed

2_objects@2x_2

Unproven But Profitable Stem Cell Clinics

JAMA features a report on the controversy of stem cell treatments for musculoskeletal (MSK) disorders. Stem cell clinics are popular and proliferating as they are largely a cash business and fall outside of … Read moreUnproven But Profitable Stem Cell Clinics

Treat-to-Target in RA: No Increase in AEs

Implementing a treat-to-target approach for the care of rheumatoid arthritis (RA) did not result in an increase in adverse events or resource use, a post-hoc analysis of a randomized trial showed. In an … Read moreTreat-to-Target in RA: No Increase in AEs

An Association between GCA and IBD ?

A population based analysis from Israel suggests that giant cell arteritis (GCA) patients may be at increased risk for  inflammatory bowel diseases (IBD) mainly target. This research was based on sporadic reports in … Read moreAn Association between GCA and IBD ?

FDA's Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) Finalized

In response to the growing opioid crisis, the US Food and Drug Administration has approved the final Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS), designed to reduce the risk of abuse, misuse, … Read moreFDA's Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) Finalized

Breast Implant Study: More Worries or Not?

The Annals of Surgery reports on an anlaysis of FDA-mandated postmarket studies, including nearly 100,000 breast implant pprocedures, that showed silicone implants to be associated with higher rates of  Sjögren’s syndrome, scleroderma, rheumatoid … Read moreBreast Implant Study: More Worries or Not?